|
Effect of Curcumin on Docetaxel-Induced Apoptosis in the DU145 (Prostate) Cell Line Using the 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide Assay
|
Mohammad Shokrzadeh1    , Elahe Gharehkhani *2 , Mahboube Rahmati Kukandeh3 , Mahsa Hosseini4 |
1- Professor, Department of Toxicology and Pharmacology, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
2- Ph.D in Toxicology, Department of Toxicology and Pharmacology, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran. , egh199012@gmail.com
3- Ph.D Candidate in Toxicology, Department of Toxicology and Pharmacology, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
4- Pharmacy Student, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Ramsar, Iran. |
|
|
Abstract: (690 Views) |
Background and Objective: Prostate cancer is one of the most common malignancies worldwide. Docetaxel (DTX) is proposed as a well-known compound for prostate tumor chemotherapy, and its function is based on inhibiting microtubule depolymerization, disrupting microtubule balance, and consequently delaying cell cycle progression. Complications of DTX include hypersensitivity reactions, red blood cell aggregation, neutropenia, neurological problems, such as paralysis, fluid retention, bronchospasm, refractory hypotension, ADRS, respiratory impairment, cardiac dysfunction, ventricular tachycardia, cystoid macular edema, optic nerve damage, conjunctivitis, and keratopathy. This study aimed to determine the effect of curcumin on DTX-induced apoptosis in the DU145 (prostate) cell line using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay.
Methods: This descriptive analytical study was conducted on the DU145 (prostate) cell line, purchased from the National Genetic Resources Cell Bank, at the Cell Culture Laboratory of the F aculty of Pharmacy, Mazandaran University of Medical Sciences. Cells were passaged for exposure to the desired drugs. Groups included curcumin at concentrations of 2, 4, 6, 8, and 10 µg/mL and DTX at a concentration of 4.46 µg/mL. Cells were incubated in triplicate for 24 hours. For the MTT assay, the culture rate was 104 cells per well. Apoptosis testing was designed for four groups (DTX at a concentration of 4.46 µM, curcumin at a concentration of 2 µM combined with DTX at an optimal concentration, curcumin at a concentration of 10 µM combined with DTX at an optimal concentration, and curcumin at a concentration of 10 µM alone), with the culture rate of 5×105 cells per well in 6-well plates. After cell exposure, MTT and apoptosis determination assays were performed.
Results: DTX reduced the viability of DU145 (prostate) cells by approximately 50% (P<0.05). Groups treated with curcumin combined with DTX showed a dose-dependent decrease in cytotoxicity and an increase in the viability of DU145 (prostate) cells (P<0.05). Additionally, curcumin was able to reduce apoptosis in DU145 (prostate) cells by 90%.
Conclusion: Curcumin increases cell viability and reduces apoptosis in DU145 (prostate) cells. |
|
Keywords: Docetaxel [MeSH], Curcumin [MeSH], Apoptosis [MeSH]
Article ID: Vol27-17 |
|
|
Full-Text [PDF 630 kb]
(405 Downloads)
| | Abstract (HTML) (8 Views)
|
|
Type of Study: Original Articles |
Subject:
Pharmacology
|
|
|
|
|
|
|
| References |
1. Maheshwari RK, Singh AK, Gaddipati J, Srimal RC. Multiple biological activities of curcumin: a short review. Life Sci. 2006 Mar;78(18):2081-87. https://doi.org/10.1016/j.lfs.2005.12.007. [ DOI] [ PubMed] 2. Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB. Curcumin and cancer: an "old-age" disease with an "age-old" solution. Cancer Lett. 2008 Aug;267(1):133-64. https://doi.org/10.1016/j.canlet.2008.03.025. [ DOI] [ PubMed] 3. Naik SR, Thakare VN, Patil SR. Protective effect of curcumin on experimentally induced inflammation, hepatotoxicity and cardiotoxicity in rats: evidence of its antioxidant property. Exp Toxicol Pathol. 2011 Jul;63(5):419-31. https://doi.org/10.1016/j.etp.2010.03.001. [ DOI] [ PubMed] 4. Singh R, Sharma P. Hepatoprotective Effect of Curcumin on Lindane-induced Oxidative Stress in Male Wistar Rats. Toxicol Int. 2011 Jul;18(2):124-29. https://doi.org/10.4103/0971-6580.84264. [ DOI] [ PubMed] 5. Rahimi HR, Nedaeinia R, Sepehri Shamloo A, Nikdoust S, Kazemi Oskuee R. Novel delivery system for natural products: Nano-curcumin formulations. Avicenna J Phytomed. 2016 Jul-Aug;6(4):383-98. [ PubMed] 6. Fang XB, Zhang JM, Xie X, Liu D, He CW, Wan JB, et al. pH-sensitive micelles based on acid-labile pluronic F68-curcumin conjugates for improved tumor intracellular drug delivery. Int J Pharm. 2016 Apr;502(1-2):28-37. https://doi.org/10.1016/j.ijpharm.2016.01.029. [ DOI] [ PubMed] 7. Chen XJ, Pang D, Li LP, Chen YQ, Tan XR. A hypothesis on the relationship between tea drinking and sexual activity. World J Hypertens. 2013;3(4):32-36. http://dx.doi.org/10.5494/wjh.v3.i4.32. [ Link] [ DOI] 8. Piskula MK, Terao J. Accumulation of (-)-epicatechin metabolites in rat plasma after oral administration and distribution of conjugation enzymes in rat tissues. J Nutr. 1998 Jul;128(7):1172-78. https://doi.org/10.1093/jn/128.7.1172. [ DOI] [ PubMed] 9. Lopes Lda S, Marques RB, Fernandes HB, Pereira Sda S, Ayres MC, Chaves MH, et al. Mechanisms of the antinociceptive action of (-) epicatechin obtained from the hydroalcoholic fraction of Combretum leprosum Mart & Eic in rodents. J Biomed Sci. 2012 Jul;19(1):68. https://doi.org/10.1186/1423-0127-19-68. [ DOI] [ PubMed] 10. Spencer JP. Flavonoids and brain health: multiple effects underpinned by common mechanisms. Genes Nutr. 2009 Dec;4(4):243-50. https://doi.org/10.1007/s12263-009-0136-3. [ DOI] [ PubMed] 11. Soltani N, Ghafouri H. Investigation of the apoptosis induction potential of synthetic sorafenib-derived compounds in breast cancer cells. JCT. 2023;13(4):298-310. https://doi.org/10.52547/JCT.13.3.298. [ Link] [ DOI] 12. Sekino Y, Teishima J. Molecular mechanisms of docetaxel resistance in prostate cancer. Cancer Drug Resist. 2020 Aug;3(4):676-85. https://doi.org/10.20517/cdr.2020.37. [ DOI] [ PubMed] 13. Carneiro BA, El-Deiry WS. Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol. 2020 Jul;17(7):395-417. https://doi.org/10.1038/s41571-020-0341-y. [ DOI] [ PubMed] 14. Voss AK, Strasser A. The essentials of developmental apoptosis. F1000Res. 2020 Feb 26;9:F1000 Faculty Rev-148. https://doi.org/10.12688/f1000research.21571.1. [ DOI] [ PubMed] 15. D'Arcy MS. Cell death: a review of the major forms of apoptosis, necrosis and autophagy. Cell Biol Int. 2019 Jun;43(6):582-92. https://doi.org/10.1002/cbin.11137. [ DOI] [ PubMed] 16. Bisht K, Wagner KH, Bulmer AC. Curcumin, resveratrol and flavonoids as anti-inflammatory, cyto- and DNA-protective dietary compounds. Toxicology. 2010 Nov;278(1):88-100. https://doi.org/10.1016/j.tox.2009.11.008. [ DOI] [ PubMed] 17. Kuhestani S, Shokrzadeh M, Aghajanshakeri S, Shokrzadeh S. [Protective Effects of Simvastatin on Cytotoxicity and Oxidative Stress in Human Gingival Fibroblasts Cells Exposed to Venlafaxine]. J Mazandaran Univ Med Sci. 2022;31(205):81-88. [Article in Persian] [ Link] 18. Banaee F, Poureini F, Mohammadi M, Najafpour GD, Moghadamnia AA. Encapsulation of curcumin in gliadin-pectin in a core–shell nanostructure for efficient delivery of curcumin to cancer cells in vitro. Colloid Polym Sci. 2022;300(9):1063-73. [ Link] 19. Ashrafizadeh M, Zarrabi A, Hashemi F, Moghadam ER, Hashemi F, Entezari M, et al. Curcumin in cancer therapy: A novel adjunct for combination chemotherapy with paclitaxel and alleviation of its adverse effects. Life Sci. 2020 Sep;256:117984. https://doi.org/10.1016/j.lfs.2020.117984. [ DOI] [ PubMed] 20. Zeng Y, Du Q, Zhang Z, Ma J, Han L, Wang Y, et al. Curcumin promotes cancer-associated fibroblasts apoptosis via ROS-mediated endoplasmic reticulum stress. Arch Biochem Biophys. 2020 Nov;694:108613. https://doi.org/10.1016/j.abb.2020.108613. [ DOI] [ PubMed] 21. Banerjee S, Singh SK, Chowdhury I, Lillard JW Jr, Singh R. Combinatorial effect of curcumin with docetaxel modulates apoptotic and cell survival molecules in prostate cancer. Front Biosci (Elite Ed). 2017 Mar;9(2):235-45. https://doi.org/10.2741/e798. [ DOI] [ PubMed] 22. Giordano A, Tommonaro G. Curcumin and Cancer. Nutrients. 2019 Oct;11(10):2376. https://doi.org/10.3390/nu11102376. [ DOI] [ PubMed] 23. Bolger GT, Pucaj K, Minta YO, Sordillo P. Relationship between the in vitro efficacy, pharmacokinetics and in vivo efficacy of curcumin. Biochem Pharmacol. 2022 Nov;205:115251. https://doi.org/10.1016/j.bcp.2022.115251. [ DOI] [ PubMed] 24. Xie L, Ji X, Zhang Q, Wei Y. Curcumin combined with photodynamic therapy, promising therapies for the treatment of cancer. Biomed Pharmacother. 2022 Feb;146:112567. https://doi.org/10.1016/j.biopha.2021.112567. [ DOI] [ PubMed] 25. Bounaama A, Djerdjouri B, Laroche-Clary A, Le Morvan V, Robert J. Short curcumin treatment modulates oxidative stress, arginase activity, aberrant crypt foci, and TGF-β1 and HES-1 transcripts in 1,2-dimethylhydrazine-colon carcinogenesis in mice. Toxicology. 2012 Dec;302(2-3):308-17. https://doi.org/10.1016/j.tox.2012.08.014. [ DOI] [ PubMed] |
|
| Send email to the article author |
|
|
|
Shokrzadeh M, Gharehkhani E, Rahmati Kukandeh M, Hosseini M. Effect of Curcumin on Docetaxel-Induced Apoptosis in the DU145 (Prostate) Cell Line Using the 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide Assay. J Gorgan Univ Med Sci 2025; 27 (2) :61-69 URL: http://goums.ac.ir/journal/article-1-4498-en.html
|
